COVID-19 Impact on Global Interventional Lung Disease Market Insights, Forecast to 2026

1 Study Coverage

• 1.1 Interventional Lung Disease Product Introduction
• 1.2 Market Segments
• 1.3 Key Interventional Lung Disease Manufacturers Covered: Ranking by Revenue
• 1.4 Market by Type
  • 1.4.1 Global Interventional Lung Disease Market Size Growth Rate by Type
  • 1.4.2 Bronchoscopes
  • 1.4.3 Respiratory Endotherapy Devices
  • 1.4.4 ENB Systems
  • 1.4.5 Pleuroscopes
  • 1.4.6 Other
• 1.5 Market by Application
  • 1.5.1 Global Interventional Lung Disease Market Size Growth Rate by Application
  • 1.5.2 Hospital
  • 1.5.3 Emergency Center
  • 1.5.4 Clinic
• 1.6 Coronavirus Disease 2019 (Covid-19): Interventional Lung Disease Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Interventional Lung Disease Industry
    • 1.6.1.1 Interventional Lung Disease Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Interventional Lung Disease Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Interventional Lung Disease Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Executive Summary

• 2.1 Global Interventional Lung Disease Market Size Estimates and Forecasts
  • 2.1.1 Global Interventional Lung Disease Revenue 2015-2026
  • 2.1.2 Global Interventional Lung Disease Sales 2015-2026
• 2.2 Interventional Lung Disease Market Size by Region: 2020 Versus 2026
  • 2.2.1 Global Interventional Lung Disease Retrospective Market Scenario in Sales by Region: 2015-2020
  • 2.2.2 Global Interventional Lung Disease Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Interventional Lung Disease Competitor Landscape by Players

• 3.1 Interventional Lung Disease Sales by Manufacturers
  • 3.1.1 Interventional Lung Disease Sales by Manufacturers (2015-2020)
  • 3.1.2 Interventional Lung Disease Sales Market Share by Manufacturers (2015-2020)
• 3.2 Interventional Lung Disease Revenue by Manufacturers
  • 3.2.1 Interventional Lung Disease Revenue by Manufacturers (2015-2020)
  • 3.2.2 Interventional Lung Disease Revenue Share by Manufacturers (2015-2020)
  • 3.2.3 Global Interventional Lung Disease Market Concentration Ratio (CR5 and HHI) (2015-2020)
  • 3.2.4 Global Top 10 and Top 5 Companies by Interventional Lung Disease Revenue in 2019
  • 3.2.5 Global Interventional Lung Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Interventional Lung Disease Price by Manufacturers
• 3.4 Interventional Lung Disease Manufacturing Base Distribution, Product Types
  • 3.4.1 Interventional Lung Disease Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Interventional Lung Disease Product Type
  • 3.4.3 Date of International Manufacturers Enter into Interventional Lung Disease Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Interventional Lung Disease Market Size by Type (2015-2020)
  • 4.1.1 Global Interventional Lung Disease Sales by Type (2015-2020)
  • 4.1.2 Global Interventional Lung Disease Revenue by Type (2015-2020)
  • 4.1.3 Interventional Lung Disease Average Selling Price (ASP) by Type (2015-2026)
• 4.2 Global Interventional Lung Disease Market Size Forecast by Type (2021-2026)
  • 4.2.1 Global Interventional Lung Disease Sales Forecast by Type (2021-2026)
  • 4.2.2 Global Interventional Lung Disease Revenue Forecast by Type (2021-2026)
  • 4.2.3 Interventional Lung Disease Average Selling Price (ASP) Forecast by Type (2021-2026)
• 4.3 Global Interventional Lung Disease Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Breakdown Data by Application (2015-2026)

• 5.1 Global Interventional Lung Disease Market Size by Application (2015-2020)
  • 5.1.1 Global Interventional Lung Disease Sales by Application (2015-2020)
  • 5.1.2 Global Interventional Lung Disease Revenue by Application (2015-2020)
  • 5.1.3 Interventional Lung Disease Price by Application (2015-2020)
• 5.2 Interventional Lung Disease Market Size Forecast by Application (2021-2026)
  • 5.2.1 Global Interventional Lung Disease Sales Forecast by Application (2021-2026)
  • 5.2.2 Global Interventional Lung Disease Revenue Forecast by Application (2021-2026)
  • 5.2.3 Global Interventional Lung Disease Price Forecast by Application (2021-2026)

6 North America

• 6.1 North America Interventional Lung Disease by Country
  • 6.1.1 North America Interventional Lung Disease Sales by Country
  • 6.1.2 North America Interventional Lung Disease Revenue by Country
  • 6.1.3 U.S.
  • 6.1.4 Canada
• 6.2 North America Interventional Lung Disease Market Facts & Figures by Type
• 6.3 North America Interventional Lung Disease Market Facts & Figures by Application

7 Europe

• 7.1 Europe Interventional Lung Disease by Country
  • 7.1.1 Europe Interventional Lung Disease Sales by Country
  • 7.1.2 Europe Interventional Lung Disease Revenue by Country
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 U.K.
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Interventional Lung Disease Market Facts & Figures by Type
• 7.3 Europe Interventional Lung Disease Market Facts & Figures by Application

8 Asia Pacific

• 8.1 Asia Pacific Interventional Lung Disease by Region
  • 8.1.1 Asia Pacific Interventional Lung Disease Sales by Region
  • 8.1.2 Asia Pacific Interventional Lung Disease Revenue by Region
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 South Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Taiwan
  • 8.1.9 Indonesia
  • 8.1.10 Thailand
  • 8.1.11 Malaysia
  • 8.1.12 Philippines
  • 8.1.13 Vietnam
• 8.2 Asia Pacific Interventional Lung Disease Market Facts & Figures by Type
• 8.3 Asia Pacific Interventional Lung Disease Market Facts & Figures by Application

9 Latin America

• 9.1 Latin America Interventional Lung Disease by Country
  • 9.1.1 Latin America Interventional Lung Disease Sales by Country
  • 9.1.2 Latin America Interventional Lung Disease Revenue by Country
  • 9.1.3 Mexico
  • 9.1.4 Brazil
  • 9.1.5 Argentina
• 9.2 Central & South America Interventional Lung Disease Market Facts & Figures by Type
• 9.3 Central & South America Interventional Lung Disease Market Facts & Figures by Application

10 Middle East and Africa

• 10.1 Middle East and Africa Interventional Lung Disease by Country
  • 10.1.1 Middle East and Africa Interventional Lung Disease Sales by Country
  • 10.1.2 Middle East and Africa Interventional Lung Disease Revenue by Country
  • 10.1.3 Turkey
  • 10.1.4 Saudi Arabia
  • 10.1.5 U.A.E
• 10.2 Middle East and Africa Interventional Lung Disease Market Facts & Figures by Type
• 10.3 Middle East and Africa Interventional Lung Disease Market Facts & Figures by Application

11 Company Profiles

• 11.1 Boston Scientific
  • 11.1.1 Boston Scientific Corporation Information
  • 11.1.2 Boston Scientific Description, Business Overview and Total Revenue
  • 11.1.3 Boston Scientific Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Boston Scientific Interventional Lung Disease Products Offered
  • 11.1.5 Boston Scientific Recent Development
• 11.2 Olympus
  • 11.2.1 Olympus Corporation Information
  • 11.2.2 Olympus Description, Business Overview and Total Revenue
  • 11.2.3 Olympus Sales, Revenue and Gross Margin (2015-2020)
  • 11.2.4 Olympus Interventional Lung Disease Products Offered
  • 11.2.5 Olympus Recent Development
• 11.3 FUJIFILM
  • 11.3.1 FUJIFILM Corporation Information
  • 11.3.2 FUJIFILM Description, Business Overview and Total Revenue
  • 11.3.3 FUJIFILM Sales, Revenue and Gross Margin (2015-2020)
  • 11.3.4 FUJIFILM Interventional Lung Disease Products Offered
  • 11.3.5 FUJIFILM Recent Development
• 11.4 Becton, Dickinson and Company
  • 11.4.1 Becton, Dickinson and Company Corporation Information
  • 11.4.2 Becton, Dickinson and Company Description, Business Overview and Total Revenue
  • 11.4.3 Becton, Dickinson and Company Sales, Revenue and Gross Margin (2015-2020)
  • 11.4.4 Becton, Dickinson and Company Interventional Lung Disease Products Offered
  • 11.4.5 Becton, Dickinson and Company Recent Development
• 11.5 Smiths Group
  • 11.5.1 Smiths Group Corporation Information
  • 11.5.2 Smiths Group Description, Business Overview and Total Revenue
  • 11.5.3 Smiths Group Sales, Revenue and Gross Margin (2015-2020)
  • 11.5.4 Smiths Group Interventional Lung Disease Products Offered
  • 11.5.5 Smiths Group Recent Development
• 11.6 Cook Medical
  • 11.6.1 Cook Medical Corporation Information
  • 11.6.2 Cook Medical Description, Business Overview and Total Revenue
  • 11.6.3 Cook Medical Sales, Revenue and Gross Margin (2015-2020)
  • 11.6.4 Cook Medical Interventional Lung Disease Products Offered
  • 11.6.5 Cook Medical Recent Development
• 11.7 Vygon
  • 11.7.1 Vygon Corporation Information
  • 11.7.2 Vygon Description, Business Overview and Total Revenue
  • 11.7.3 Vygon Sales, Revenue and Gross Margin (2015-2020)
  • 11.7.4 Vygon Interventional Lung Disease Products Offered
  • 11.7.5 Vygon Recent Development
• 11.8 PENTAX Medical
  • 11.8.1 PENTAX Medical Corporation Information
  • 11.8.2 PENTAX Medical Description, Business Overview and Total Revenue
  • 11.8.3 PENTAX Medical Sales, Revenue and Gross Margin (2015-2020)
  • 11.8.4 PENTAX Medical Interventional Lung Disease Products Offered
  • 11.8.5 PENTAX Medical Recent Development
• 11.9 Clarus Medical
  • 11.9.1 Clarus Medical Corporation Information
  • 11.9.2 Clarus Medical Description, Business Overview and Total Revenue
  • 11.9.3 Clarus Medical Sales, Revenue and Gross Margin (2015-2020)
  • 11.9.4 Clarus Medical Interventional Lung Disease Products Offered
  • 11.9.5 Clarus Medical Recent Development
• 11.10 HUGER Medical Instrument
  • 11.10.1 HUGER Medical Instrument Corporation Information
  • 11.10.2 HUGER Medical Instrument Description, Business Overview and Total Revenue
  • 11.10.3 HUGER Medical Instrument Sales, Revenue and Gross Margin (2015-2020)
  • 11.10.4 HUGER Medical Instrument Interventional Lung Disease Products Offered
  • 11.10.5 HUGER Medical Instrument Recent Development
• 11.1 Boston Scientific
  • 11.1.1 Boston Scientific Corporation Information
  • 11.1.2 Boston Scientific Description, Business Overview and Total Revenue
  • 11.1.3 Boston Scientific Sales, Revenue and Gross Margin (2015-2020)
  • 11.1.4 Boston Scientific Interventional Lung Disease Products Offered
  • 11.1.5 Boston Scientific Recent Development
• 11.12 Karl Storz
  • 11.12.1 Karl Storz Corporation Information
  • 11.12.2 Karl Storz Description, Business Overview and Total Revenue
  • 11.12.3 Karl Storz Sales, Revenue and Gross Margin (2015-2020)
  • 11.12.4 Karl Storz Products Offered
  • 11.12.5 Karl Storz Recent Development
• 11.13 Taewoong Medical
  • 11.13.1 Taewoong Medical Corporation Information
  • 11.13.2 Taewoong Medical Description, Business Overview and Total Revenue
  • 11.13.3 Taewoong Medical Sales, Revenue and Gross Margin (2015-2020)
  • 11.13.4 Taewoong Medical Products Offered
  • 11.13.5 Taewoong Medical Recent Development
• 11.14 ELLA - CS
  • 11.14.1 ELLA - CS Corporation Information
  • 11.14.2 ELLA - CS Description, Business Overview and Total Revenue
  • 11.14.3 ELLA - CS Sales, Revenue and Gross Margin (2015-2020)
  • 11.14.4 ELLA - CS Products Offered
  • 11.14.5 ELLA - CS Recent Development

12 Future Forecast by Regions (Countries) (2021-2026)

• 12.1 Interventional Lung Disease Market Estimates and Projections by Region
  • 12.1.1 Global Interventional Lung Disease Sales Forecast by Regions 2021-2026
  • 12.1.2 Global Interventional Lung Disease Revenue Forecast by Regions 2021-2026
• 12.2 North America Interventional Lung Disease Market Size Forecast (2021-2026)
  • 12.2.1 North America: Interventional Lung Disease Sales Forecast (2021-2026)
  • 12.2.2 North America: Interventional Lung Disease Revenue Forecast (2021-2026)
  • 12.2.3 North America: Interventional Lung Disease Market Size Forecast by Country (2021-2026)
• 12.3 Europe Interventional Lung Disease Market Size Forecast (2021-2026)
  • 12.3.1 Europe: Interventional Lung Disease Sales Forecast (2021-2026)
  • 12.3.2 Europe: Interventional Lung Disease Revenue Forecast (2021-2026)
  • 12.3.3 Europe: Interventional Lung Disease Market Size Forecast by Country (2021-2026)
• 12.4 Asia Pacific Interventional Lung Disease Market Size Forecast (2021-2026)
  • 12.4.1 Asia Pacific: Interventional Lung Disease Sales Forecast (2021-2026)
  • 12.4.2 Asia Pacific: Interventional Lung Disease Revenue Forecast (2021-2026)
  • 12.4.3 Asia Pacific: Interventional Lung Disease Market Size Forecast by Region (2021-2026)
• 12.5 Latin America Interventional Lung Disease Market Size Forecast (2021-2026)
  • 12.5.1 Latin America: Interventional Lung Disease Sales Forecast (2021-2026)
  • 12.5.2 Latin America: Interventional Lung Disease Revenue Forecast (2021-2026)
  • 12.5.3 Latin America: Interventional Lung Disease Market Size Forecast by Country (2021-2026)
• 12.6 Middle East and Africa Interventional Lung Disease Market Size Forecast (2021-2026)
  • 12.6.1 Middle East and Africa: Interventional Lung Disease Sales Forecast (2021-2026)
  • 12.6.2 Middle East and Africa: Interventional Lung Disease Revenue Forecast (2021-2026)
  • 12.6.3 Middle East and Africa: Interventional Lung Disease Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Porter’s Five Forces Analysis
• 13.5 Primary Interviews with Key Interventional Lung Disease Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Interventional Lung Disease Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source